Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research
NCT ID: NCT02693496
Last Updated: 2018-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2015-10-31
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
From Benchmark to Surgical Activity: the Role of Endobronchial Fiducial Markers for Ground Glass Lung Nodules Resection.
NCT05801406
A Prospective Cohort Study of Chinese Patients With Pulmonary Nodules: Prediction of Lung Cancer Using Noninvasive Biomarkers
NCT04462185
Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy Combination
NCT02268162
3D Printing for Nodule Localization
NCT04056923
Screening for Early Lung Cancer in Shanghai, China
NCT02185495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
What is the optimal way to manage this CT finding? Should we adopt surgical removal or just observation? An optimal solution is to determine a clearly defined standard of care that is easy to learn. We propose a method called "three plus two". The 'Three' is a three-step testing method, and the 'Two' means two alternative solutions. Three-step testing method includes collecting medical history, non-invasive examination, and invasive examination. The two alternative solutions are surgical removal and follow-up observation. We have independently developed an application based on a smartphone platform. This platform will provide a novel evidence-based research method for observing the dynamic evolution of the lung nodules in patients. There have been no prior studies about managing this CT scan finding, either in China or internationally.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Installation or registration of smartphone application
Completed the installation and registration of mobile terminal software online
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* There is a chest lesion less than 3cm width (examined by Thin-Section CT)
* The patient or his family member owns a smartphone
* Signed informed consent
* Completed the installation and registration of mobile terminal software online
* Willing to complete a 10-year period of follow-up
Exclusion Criteria
* Cannot complete the installation or registration of smartphone application software online
* Received prior chemotherapy medications for lung cancer or received lung surgical removal treatment
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese Alliance Against Lung Cancer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bai Chunxue
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chunxue Bai, M.D, Ph.D
Role: STUDY_CHAIR
Chinese Alliance Against Lung Cancer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Union Hospital
Beijing, , China
General Hospital of PLA
Beijing, , China
Hebei Pronvince Cangzhou City People's Hospital
Cangzhou, , China
Xiaya Hospital Central South Unversity
Changsha, , China
Anhui Province Chaoyang Hospital
Chaoyang, , China
West China Hospital Sichuan University
Chengdu, , China
No.1 Hospital Chongqing Medical University
Chongqing, , China
Western East Hospital No. 3 PLA Medical University
Chongqing, , China
No. 2 Hospital Dalian Medical University
Dalian, , China
Guizhou Province People's Hospital
Guizhou, , China
International Hospital Zhejiang University
Hangzhou, , China
No. 1 Hospital Zhejiang University Medical College
Hangzhou, , China
Yunnan Province Cancer Hospital
Kunming, , China
Shandong Province Liaocheng City People's Hospital
Liaocheng, , China
No. 2 Hospital Fujian Medical University
Quanzhou, , China
Kecheng District Hospital
Quzhou, , China
Shanghai Zhongshan Hospital
Shanghai, , China
Minhang District Hospital Fudan University
Shanghai, , China
Putuo District Central Hospital Shanghai Chinese Medical University
Shanghai, , China
Ruici Clinic
Shanghai, , China
No. 2 Hospital Tianjin Chinese Medical University
Tianjin, , China
Weifang City No.2 People's Hospital
Weifang, , China
Wudang Hospital Guiyang Medical College
Wudang, , China
Wuhu City No. 2 Hopsital
Wuhu, , China
No. 5 Wuxi People's Hospital
Wuxi, , China
Xining Hospital No.4 PLA University
Xi'an, , China
Xiamen City No.3 People's Hospital
Xiamen, , China
Yantai City Taishan Hopsital
Yantai, , China
Henan Province People's Hospital
Zhengzhou, , China
No. 1 Hospital Zhengzhou University
Zhengzhou, , China
Shandong Pronvince Zibo City Official Hospital
Zibo, , China
Shandong Province Linzi District Hospital
Zibo, , China
Sichuan Province Zigong City No. 1 Hospital
Zigong, , China
Guizhou Province Zunyi Medical College Hospital
Zunyi, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Yang DW, Zhang Y, Hong QY, Hu J, Li C, Pan BS, Wang Q, Ding FH, Ou JX, Liu FL, Zhang D, Zhou JB, Song YL, Bai CX. Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients. Cancer. 2015 Sep 1;121 Suppl 17:3113-21. doi: 10.1002/cncr.29551.
Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, Wiener RS. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):e93S-e120S. doi: 10.1378/chest.12-2351.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAALC-002-mLOWER
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.